TOPP7 Antibody

Terminology Clarification

The term "TOPP7" does not correspond to any recognized antibody, protein, or biomarker in major databases (e.g., UniProt, PubMed, AntibodyRegistry). Potential sources of confusion include:

• TOPORS (Topoisomerase I-Binding Protein): A protein studied in ubiquitination and DNA repair (Search Result 10).

• Topoisomerase I Antibodies: Well-characterized autoantibodies in systemic sclerosis (e.g., anti-Scl-70) (Search Results 3, 4, 8).

• Phospho-Specific Antibodies: CiteAb’s top-cited antibodies (e.g., Phospho-Akt, Phospho-Stat3) lack any association with "TOPP7" (Search Result 5).

a. Autoantibody Repertoire in Disease

Studies on chronic obstructive pulmonary disease (COPD) and tuberculosis-associated COPD identified autoantibodies targeting PCNA, MAPK3, and AKT1 but made no mention of "TOPP7" (Search Result 1).

b. Topoisomerase Antibodies

• Anti-topoisomerase I (anti-topo I) antibodies are validated biomarkers in systemic sclerosis, linked to lung fibrosis and skin involvement (Search Results 3, 4, 8).

• Commercial antibodies (e.g., Abcam’s ab109374) target Topoisomerase I, not "TOPP7" (Search Result 9).

c. Nanobodies and Antibody Engineering

Research on nanobodies for viral neutralization (e.g., SARS-CoV-2) and bovine ultralong CDR H3 antibodies revealed no overlap with "TOPP7" (Search Results 6, 7).

Potential Explanations for the Query

• Typographical Error: "TOPP7" may refer to TOPORS (E3 ubiquitin-protein ligase) or Topoisomerase I/II antibodies, both well-documented in the literature.

• Provisional or Obsolete Designation: The term might represent an unpublished or discontinued antibody candidate.

• Misinterpretation of Nomenclature: Confusion between gene names (e.g., TOP1 for Topoisomerase I) and antibody clones.

Recommendations for Further Research

To resolve ambiguity, consider:

1. Re-verifying the Target Name with genomic databases (e.g., NCBI Gene, UniProt).

2. Exploring Homologous Proteins:

   • TOPORS (TOP1-binding protein): Involved in p53 regulation and ubiquitination (Search Result 10).

   • Anti-Topo I Antibodies: Clinical relevance in autoimmune diseases (Search Results 3, 8).

3. Contacting Antibody Manufacturers for clarification on unpublished or proprietary reagents.